EUVIMEDEUVIMED entdecken
Editorial

Anticoagulation in cirrhosis: from stroke prevention to disease modification?: Editorial on “Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study”

Jae Hyun Yoon

Clinical and Molecular Hepatology · 06.11.2026

DOI: 10.3350/cmh.2026.1061 ↗

Kurz gefasst

Editorial in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 06.11.2026. Verfasst von Jae Hyun Yoon.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yoon, J. H. (2026). Anticoagulation in cirrhosis: from stroke prevention to disease modification?: Editorial on “Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study”. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.1061

Vancouver

Yoon JH. Anticoagulation in cirrhosis: from stroke prevention to disease modification?: Editorial on “Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study”. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.1061

BibTeX
@article{Yoon2026,
  author = {Yoon, Jae Hyun},
  title = {Anticoagulation in cirrhosis: from stroke prevention to disease modification?: Editorial on “Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study”},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  doi = {10.3350/cmh.2026.1061}
}
Kostenlos starten →